2018 Public Policy Year in Review: what did ACG do for you?

2018 Public Policy Year in Review:   What did ACG do for you?   Another look at last year’s important policy highlights. December November October September August July June May April March February January December ...

FDA Safety Communication: FDA Provides Interim Results of Duodenoscope Reprocessing Studies Conducted in Real-World Settings

Stephen B. Hanauer, MD, FACG Chair, ACG FDA Related Matters Committee On December 10, the U.S. Food & Drug Administration (FDA) released interim results from post-market surveillance studies on contamination rates with duodenoscopes after ...

Important FDA Safety Alerts in GI: What you need to know

Boxed warning for Ocaliva (obeticholic acid) The U.S. Food and Drug Administration (FDA) issued a warning this week stating that the liver disease medicine Ocaliva (obeticholic acid) has been incorrectly dosed daily instead of weekly in patients ...

From the ACG Governors: Updated on Saline Shortages

The ACG Board of Governors meets regularly throughout the year to discuss important clinical and practice management issues impacting ACG members and our patients.  The ACG Governors recently met in Las Vegas during the 2018 ACG IBD School ...

2017 Public Policy and Practice Management Year in Review: what did ACG do for you?

2017 Public Policy and Practice Management Year in Review:   What did ACG do for you?   Another look at last year’s important policy highlights. December November October September August July June May April March February January December ...

2016 ACG National Affairs News Year in Review: ACG in Washington D.C. and State Houses across the Country

Year in Review: ACG in Washington D.C. and State Houses across the Country   ACG on Capitol Hill and Washington D.C.: ACG-FDA Visiting Fellowship Program: Dr. Kendall Beck’s Experience at the FDA Congress passes 21st Century Cures Act:  ...